Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list
Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...
The Washington Post4d
Novo Nordisk slashes Wegovy price for patients lacking insurance benefits
the active ingredient in Wegovy as well as diabetes drug Ozempic. The FDA had listed semaglutide in shortage for more than two years as Novo Nordisk struggled to meet the seemingly bottomless ...
Novo to test if GLP-1 weight loss drugs can help curb addiction
Novo Nordisk (NVO) plans to study how its GLP-1 drugs marketed as Wegovy and Ozempic for obesity and diabetes can help tackle ...
Reuters3d
Novo Nordisk to explore how GLP-1 drugs can help patients with addiction
GLP-1 drugs on the market include Novo Nordisk's diabetes drug Ozempic, its weight-loss treatment Wegovy and Eli Lilly's (LLY.N), opens new tab obesity drug Zepbound. But the class of ...